Skip to main content
Clinical Trials/ISRCTN10401966
ISRCTN10401966
Active, not recruiting
未知

Feasibility study of a supported self-management intervention for stroke survivors with aphasia (StarStep study)

niversity of Leeds0 sites30 target enrollmentOctober 7, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Stroke
Sponsor
niversity of Leeds
Enrollment
30
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 7, 2022
End Date
October 1, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Leeds

Eligibility Criteria

Inclusion Criteria

  • Stroke survivors with aphasia:
  • 1\. Are aged 16 years or over
  • 2\. Have a primary diagnosis of stroke
  • 3\. Have post\-stroke aphasia (as diagnosed by the treating speech and language therapy service)
  • 4\. Are \=12 months post\-stroke
  • 5\. Are able and willing to provide informed consent for participating in data collection (e.g. questionnaires or observations or a semi\-structured interview) or for whom a consultee declaration is provided (observations only)
  • 6\. Living at an address within the remit of a participating community service and referred for speech and language therapy from a participating community service
  • Family members or friends:
  • 1\. Are aged 16 years or over
  • 2\. Are a family member/close friend and/or carer of a stroke survivor with aphasia participating in the study or are a family member/close friend and/or carer of a stroke survivor with aphasia who lacks the capacity to consent to participate in the study

Exclusion Criteria

  • Stroke survivors with aphasia:
  • 1\. \>12 months post\-stroke
  • 2\. Already in receipt of speech and language therapy from the community stroke team
  • 3\. In receipt of end\-of\-life care (documented in medical notes)
  • 4\. Residents in nursing or care homes
  • 5\. People with comorbid progressive neurological disorders, e.g. Huntington’s disease, motor neurone disease, Parkinson’s disease, multiple sclerosis
  • Family members or friends:
  • 1\. They are caring for a stroke survivor resident in a nursing or care home or with palliative care needs
  • 2\. They are caring for a stroke survivor with a comorbid progressive neurological disorder e.g. Huntington’s disease, motor neurone disease, Parkinson's disease, or multiple sclerosis
  • Speech and language therapists:

Outcomes

Primary Outcomes

Not specified

Similar Trials